Combination Merestinib and LY2874455 for Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT03125239 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Relapsed Adult Acute Myeloid Leukemia
Refractory Adult Acute Myeloid Leukemia

Interventions

DRUG: Merestinib
DRUG: LY2874455

Sponsor

Jacqueline Garcia, MD

Collaborators

[object Object]